AI in Regulatory Affairs Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global AI in Regulatory Affairs Market Size Analysis

Global AI in Regulatory Affairs Market Introduction
By Component
1. Introduction
  1. Component By Value
2. Software/Platform
  1. By Value
3. Services
  1. By Value
By Deployment Mode
1. Introduction
  1. Deployment Mode By Value
2. Cloud-based
  1. By Value
3. On-Premises
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Regulatory Intelligence
  1. By Value
3. Data Migration & Integration
  1. By Value
4. Dossier Management
  1. By Value
5. Document Management
  1. By Value
6. Product Registration & Approvals
  1. By Value
7. Pharmacovigilance & Safety Reporting
  1. By Value
8. Regulatory Submissions & Publishing
  1. By Value
9. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical Companies
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Medical Device Companies
  1. By Value
5. CRO/CDMO
  1. By Value
6. Others
  1. By Value

North America Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software/Platform
  1. By Value
3. Services
  1. By Value
By Deployment Mode
1. Introduction
  1. Deployment Mode By Value
2. Cloud-based
  1. By Value
3. On-Premises
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Regulatory Intelligence
  1. By Value
3. Data Migration & Integration
  1. By Value
4. Dossier Management
  1. By Value
5. Document Management
  1. By Value
6. Product Registration & Approvals
  1. By Value
7. Pharmacovigilance & Safety Reporting
  1. By Value
8. Regulatory Submissions & Publishing
  1. By Value
9. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical Companies
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Medical Device Companies
  1. By Value
5. CRO/CDMO
  1. By Value
6. Others
  1. By Value
U.S.
1. By Component
  1. Introduction
    1. Component By Value
  2. Software/Platform
    1. By Value
  3. Services
    1. By Value
2. By Deployment Mode
  1. Introduction
    1. Deployment Mode By Value
  2. Cloud-based
    1. By Value
  3. On-Premises
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Regulatory Intelligence
    1. By Value
  3. Data Migration & Integration
    1. By Value
  4. Dossier Management
    1. By Value
  5. Document Management
    1. By Value
  6. Product Registration & Approvals
    1. By Value
  7. Pharmacovigilance & Safety Reporting
    1. By Value
  8. Regulatory Submissions & Publishing
    1. By Value
  9. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical Companies
    1. By Value
  3. Biotechnology Companies
    1. By Value
  4. Medical Device Companies
    1. By Value
  5. CRO/CDMO
    1. By Value
  6. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software/Platform
  1. By Value
3. Services
  1. By Value
By Deployment Mode
1. Introduction
  1. Deployment Mode By Value
2. Cloud-based
  1. By Value
3. On-Premises
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Regulatory Intelligence
  1. By Value
3. Data Migration & Integration
  1. By Value
4. Dossier Management
  1. By Value
5. Document Management
  1. By Value
6. Product Registration & Approvals
  1. By Value
7. Pharmacovigilance & Safety Reporting
  1. By Value
8. Regulatory Submissions & Publishing
  1. By Value
9. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical Companies
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Medical Device Companies
  1. By Value
5. CRO/CDMO
  1. By Value
6. Others
  1. By Value
U.K.
1. By Component
  1. Introduction
    1. Component By Value
  2. Software/Platform
    1. By Value
  3. Services
    1. By Value
2. By Deployment Mode
  1. Introduction
    1. Deployment Mode By Value
  2. Cloud-based
    1. By Value
  3. On-Premises
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Regulatory Intelligence
    1. By Value
  3. Data Migration & Integration
    1. By Value
  4. Dossier Management
    1. By Value
  5. Document Management
    1. By Value
  6. Product Registration & Approvals
    1. By Value
  7. Pharmacovigilance & Safety Reporting
    1. By Value
  8. Regulatory Submissions & Publishing
    1. By Value
  9. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical Companies
    1. By Value
  3. Biotechnology Companies
    1. By Value
  4. Medical Device Companies
    1. By Value
  5. CRO/CDMO
    1. By Value
  6. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software/Platform
  1. By Value
3. Services
  1. By Value
By Deployment Mode
1. Introduction
  1. Deployment Mode By Value
2. Cloud-based
  1. By Value
3. On-Premises
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Regulatory Intelligence
  1. By Value
3. Data Migration & Integration
  1. By Value
4. Dossier Management
  1. By Value
5. Document Management
  1. By Value
6. Product Registration & Approvals
  1. By Value
7. Pharmacovigilance & Safety Reporting
  1. By Value
8. Regulatory Submissions & Publishing
  1. By Value
9. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical Companies
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Medical Device Companies
  1. By Value
5. CRO/CDMO
  1. By Value
6. Others
  1. By Value
China
1. By Component
  1. Introduction
    1. Component By Value
  2. Software/Platform
    1. By Value
  3. Services
    1. By Value
2. By Deployment Mode
  1. Introduction
    1. Deployment Mode By Value
  2. Cloud-based
    1. By Value
  3. On-Premises
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Regulatory Intelligence
    1. By Value
  3. Data Migration & Integration
    1. By Value
  4. Dossier Management
    1. By Value
  5. Document Management
    1. By Value
  6. Product Registration & Approvals
    1. By Value
  7. Pharmacovigilance & Safety Reporting
    1. By Value
  8. Regulatory Submissions & Publishing
    1. By Value
  9. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical Companies
    1. By Value
  3. Biotechnology Companies
    1. By Value
  4. Medical Device Companies
    1. By Value
  5. CRO/CDMO
    1. By Value
  6. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software/Platform
  1. By Value
3. Services
  1. By Value
By Deployment Mode
1. Introduction
  1. Deployment Mode By Value
2. Cloud-based
  1. By Value
3. On-Premises
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Regulatory Intelligence
  1. By Value
3. Data Migration & Integration
  1. By Value
4. Dossier Management
  1. By Value
5. Document Management
  1. By Value
6. Product Registration & Approvals
  1. By Value
7. Pharmacovigilance & Safety Reporting
  1. By Value
8. Regulatory Submissions & Publishing
  1. By Value
9. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical Companies
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Medical Device Companies
  1. By Value
5. CRO/CDMO
  1. By Value
6. Others
  1. By Value
UAE
1. By Component
  1. Introduction
    1. Component By Value
  2. Software/Platform
    1. By Value
  3. Services
    1. By Value
2. By Deployment Mode
  1. Introduction
    1. Deployment Mode By Value
  2. Cloud-based
    1. By Value
  3. On-Premises
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Regulatory Intelligence
    1. By Value
  3. Data Migration & Integration
    1. By Value
  4. Dossier Management
    1. By Value
  5. Document Management
    1. By Value
  6. Product Registration & Approvals
    1. By Value
  7. Pharmacovigilance & Safety Reporting
    1. By Value
  8. Regulatory Submissions & Publishing
    1. By Value
  9. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical Companies
    1. By Value
  3. Biotechnology Companies
    1. By Value
  4. Medical Device Companies
    1. By Value
  5. CRO/CDMO
    1. By Value
  6. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software/Platform
  1. By Value
3. Services
  1. By Value
By Deployment Mode
1. Introduction
  1. Deployment Mode By Value
2. Cloud-based
  1. By Value
3. On-Premises
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Regulatory Intelligence
  1. By Value
3. Data Migration & Integration
  1. By Value
4. Dossier Management
  1. By Value
5. Document Management
  1. By Value
6. Product Registration & Approvals
  1. By Value
7. Pharmacovigilance & Safety Reporting
  1. By Value
8. Regulatory Submissions & Publishing
  1. By Value
9. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical Companies
  1. By Value
3. Biotechnology Companies
  1. By Value
4. Medical Device Companies
  1. By Value
5. CRO/CDMO
  1. By Value
6. Others
  1. By Value
Brazil
1. By Component
  1. Introduction
    1. Component By Value
  2. Software/Platform
    1. By Value
  3. Services
    1. By Value
2. By Deployment Mode
  1. Introduction
    1. Deployment Mode By Value
  2. Cloud-based
    1. By Value
  3. On-Premises
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Regulatory Intelligence
    1. By Value
  3. Data Migration & Integration
    1. By Value
  4. Dossier Management
    1. By Value
  5. Document Management
    1. By Value
  6. Product Registration & Approvals
    1. By Value
  7. Pharmacovigilance & Safety Reporting
    1. By Value
  8. Regulatory Submissions & Publishing
    1. By Value
  9. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical Companies
    1. By Value
  3. Biotechnology Companies
    1. By Value
  4. Medical Device Companies
    1. By Value
  5. CRO/CDMO
    1. By Value
  6. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

AI in Regulatory Affairs Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

IQVIA
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Freyr Solutions
Nemko Group AS
DDReg Pharma
ArisGlobal
RegASK
IBM
Oracle
Microsoft
Google (Alphabet)
Tempus AI
Accenture
Wipro
Zenovel
EVERSANA
Innoplexus
Workiva
ComplyAdvantage
MetricStream
Viz.ai
Veeva Systems
Clarivate
RegAsk

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment